| Dr Richard Davis Flanagan, PHD | |
|
3131 Barley Mill Rd, Hockessin, DE 19707-9650 | |
| (302) 239-2078 | |
| Not Available |
| Full Name | Dr Richard Davis Flanagan |
|---|---|
| Gender | Male |
| Speciality | Psychologist |
| Location | 3131 Barley Mill Rd, Hockessin, Delaware |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1720480296 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103T00000X | Psychologist | B1-0000117 (Delaware) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Richard Davis Flanagan, PHD 3131 Barley Mill Rd, Hockessin, DE 19707-9650 Ph: (302) 239-2078 | Dr Richard Davis Flanagan, PHD 3131 Barley Mill Rd, Hockessin, DE 19707-9650 Ph: (302) 239-2078 |
News Archive
A new study by UCLA scientists has found that the breakthrough immunotherapy drug pembrolizumab can be more effective in improving survival in people with non-small cell lung cancer (NSCLC) if they have previously received radiation therapy, compared to those without a history of radiation treatment.
Impact Sports Technologies, Inc., the industry leader in innovative motion resistant strapless heart rate applications, has received its 18th patent, featuring the use of its mobile optical heart rate monitoring technology with a mobile communications device.
A new preclinical study on triple negative breast cancer (TNBC) reports that an experimental polo-like kinase 1 (PLK1) inhibitor shrank tumor four times more powerfully when used along with standard drugs than alone. The study, reported in the journal PLOS ONE, opens up a new door of opportunity for patients with this disease.
Genentech, Inc., a wholly-owned member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), and Biogen Idec announced today that the U.S. Food and Drug Administration (FDA) issued a complete response on the companies' applications for Rituxan® (rituximab) plus fludarabine and cyclophosphamide (FC) for the treatment of people with previously untreated and previously treated chronic lymphocytic leukemia (CLL).
› Verified 5 days ago
Dr. Dahra Jackson Williams, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 710 Yorklyn Road, Hockessin, DE 19707 Phone: 302-238-5255 Fax: 302-239-5531 | |
Dr. Monica Elizabeth Bocanegra, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 710 Yorklyn Rd, Hockessin, DE 19707 Phone: 302-239-5255 Fax: 302-239-5531 | |
Dr. Stephanie Joyce Traynor, PSYD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1213 Old Lancaster Pike, Hockessin, DE 19707 Phone: 302-593-4675 Fax: 302-235-2672 | |
Elizabeth Higley, PHD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 710 Yorklyn Rd, Hockessin, DE 19707 Phone: 302-239-5255 | |
Dr. Mark P Carney, PSY.D. Psychologist Medicare: Accepting Medicare Assignments Practice Location: 614 Loveville Rd Ste F1a, Hockessin, DE 19707 Phone: 302-235-1860 Fax: 302-425-0194 | |
Johanna Carpenter Lyden, PHD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 710 Yorklyn Rd Ste 100, Hockessin, DE 19707 Phone: 302-239-5255 Fax: 302-239-5531 | |
Dr. Mary Anne M Lacour, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 614 Loveville Rd Ste F1a, Hockessin, DE 19707 Phone: 302-234-9447 Fax: 302-235-8984 |